circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis

[1]  S. Gerstberger,et al.  Metastasis , 2023, Cell.

[2]  Ruimin Huang,et al.  Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance. , 2023, Cancer research.

[3]  W. Fan,et al.  Epithelial cells activate fibroblasts to promote esophageal cancer development. , 2023, Cancer cell.

[4]  Rushikesh S. Joshi,et al.  Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects , 2023, The Journal of clinical investigation.

[5]  L. Stegger,et al.  Fibroblast Activation Protein triggers release of drug payload from non-internalizing small molecule-drug conjugates in solid tumors. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Yuhe Huang,et al.  The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis , 2022, Journal of Hematology & Oncology.

[7]  Yueping Liu,et al.  Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer , 2022, Journal of Cancer Research and Clinical Oncology.

[8]  R. Kalluri,et al.  Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL-6 Mediated Therapy Resistance in Pancreatic Cancer. , 2022, Cancer discovery.

[9]  Quanbo Zhou,et al.  circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway , 2022, Journal of experimental & clinical cancer research : CR.

[10]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[11]  Zihua Wang,et al.  Fibroblast Activation Protein-α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy. , 2021, Small.

[12]  J. Kjems,et al.  The emerging roles of circRNAs in cancer and oncology , 2021, Nature Reviews Clinical Oncology.

[13]  Lihua Liu,et al.  Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin , 2021, Molecular Cancer.

[14]  R. Kalluri,et al.  Clinical and therapeutic relevance of cancer-associated fibroblasts , 2021, Nature Reviews Clinical Oncology.

[15]  Q. Zhan,et al.  NOX5 mediates the crosstalk between tumor cells and cancer‐associated fibroblasts via regulating cytokine network , 2021, Clinical and translational medicine.

[16]  N. Almog,et al.  Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. , 2021, Cancer cell.

[17]  A. Orimo,et al.  Phenotypic heterogeneity, stability and plasticity in tumor‐promoting carcinoma‐associated fibroblasts , 2021, The FEBS journal.

[18]  Hua Wu,et al.  Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers. , 2020, Radiology.

[19]  L. Liu,et al.  LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1. , 2020, European review for medical and pharmacological sciences.

[20]  J. Kjems,et al.  Spatial expression analyses of the putative oncogene ciRS-7 in cancer reshape the microRNA sponge theory , 2020, Nature Communications.

[21]  D. Ma,et al.  hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis. , 2020, Epigenomics.

[22]  L. Weiner,et al.  The role of fibroblast activation protein in health and malignancy , 2020, Cancer and Metastasis Reviews.

[23]  Gary D Bader,et al.  Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21 , 2020, The Journal of experimental medicine.

[24]  Yihai Cao,et al.  Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation , 2020, Nature Communications.

[25]  Jian-hua Zhou,et al.  microRNA‐30a attenuates TGF‐β1–induced activation of pulmonary fibroblast cell by targeting FAP‐α , 2020, Journal of cellular and molecular medicine.

[26]  T. Watabe,et al.  Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models , 2019, The Journal of Nuclear Medicine.

[27]  P. Robson,et al.  Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. , 2019, Cancer discovery.

[28]  L. Butler,et al.  Cancer-associated fibroblasts—heroes or villains? , 2019, British Journal of Cancer.

[29]  X. Cui,et al.  Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation. , 2019, Cancer letters.

[30]  Toshio Tanaka,et al.  Targeting Interleukin-6 Signaling in Clinic. , 2019, Immunity.

[31]  H. Kauczor,et al.  68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer , 2019, The Journal of Nuclear Medicine.

[32]  R. Brekken,et al.  Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer , 2019, Molecular Cancer.

[33]  G. Ullenhag,et al.  First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies , 2019, International journal of cancer.

[34]  Xiao-Hua Cheng,et al.  The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Xuetao Cao,et al.  Characteristics and Significance of the Pre-metastatic Niche. , 2016, Cancer cell.

[36]  C. Gaggioli,et al.  Fibroblast activation in cancer: when seed fertilizes soil , 2016, Cell and Tissue Research.

[37]  S. Nam,et al.  Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer , 2015, Cell Death and Differentiation.

[38]  S. Rosenberg,et al.  Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia , 2013, The Journal of experimental medicine.

[39]  James O. Jones,et al.  Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia , 2013, The Journal of experimental medicine.

[40]  D. Kranz.  Faculty Opinions recommendation of Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. , 2010 .

[41]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α , 2010, Science.

[42]  C. Garlanda,et al.  Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.

[43]  L. Old,et al.  Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. , 1986, Cancer research.